Search
for
Sort by
Research 811–840 of 1000+
- The use of topical ruxolitinib 1.5% cream in frontal fibrosing alopecia: A case report
- Evolution of Ritlecitinib Population Pharmacokinetic Models During Clinical Drug Development
- Baricitinib for the Treatment of Alopecia Areata
- Management of folliculitis decalvans with ayurveda- A case report
- <i>Lagerstroemia indica</i> extract regulates human hair dermal papilla cell growth and degeneration via modulation of β‐catenin, Stat6, and TGF‐β signaling pathway
- Gut instinct: Using tofacitinib to treat alopecia areata in the context of comorbid inflammatory bowel disease
- Frontal fibrosing alopecia: a disease fascinating for the researcher, disappointing for the clinician and distressing for the patient
- Notch1 Signaling Regulates Wound Healing via Changing the Characteristics of Epidermal Stem Cells
- Genes and Immune Response in Alopecia Areata: Review of the Alopecia Areata Research Summit First Day Proceedings
- Regulatory network of ginsenoside biosynthesis under Ro stress in the hairy roots of Panax ginseng revealed by RNA sequencing
- Sudden improvement of alopecia universalis and psoriatic arthritis while receiving upadacitinib: a case-based review
- Refractory alopecia in lupus treated with tofacitinib — a case-based review
- Immune therapies for alopecia areata: evidence and new perspectives
- Global burden of alopecia areata from 1990 to 2019 and emerging treatment trends analyzed through GBD 2019 and bibliometric data
- Management of folliculitis decalvans: The EADV task force on hair diseases position statement
- The Relative Efficacy and Safety of Monotherapies for Alopecia Areata: A Network Meta‐Analysis Study
- Pathophysiology of Alopecia Areata in the Pediatric Patient
- A Phase 1, Open‐Label Study of the Pharmacokinetics of Ritlecitinib in Children Aged 6–12 Years With Alopecia Areata
- II Consensus of the Brazilian Society of Dermatology for the treatment of alopecia areata
- Successful treatment of severe atopic dermatitis and alopecia universalis with upadacitinib in a 29-year-old male patient
- Moving Beyond Boundaries: Utilization of Longitudinal Exposure–Response Model for Bounded Outcome Score to Inform Decision Making in the Accelerated Drug Development Paradigm
- Two phase III trials of baricitinib for alopecia areata: a critically appraised research paper
- Prediction of the Mechanism of Shaoyao Gancao Decoction in the Treatment of Alopecia Areata by Network Pharmacology and Its Preliminary Verification Study
- Acne exacerbation after tofacitinib treatment for alopecia areata
- Tofacitinib for the Treatment of Three Immune-mediated Conditions in One Patient: Ulcerative Colitis, Pyoderma Gangrenosum, and Alopecia Areata
- Childhood Alopecia Areata: An Overview of Treatment and Recent Patents
- Apremilast and tofacitinib exert differential effects in the humanized mouse model of alopecia areata
- What’s New in Hair Loss
- Integrated single-cell chromatin and transcriptomic analyses of peripheral immune cells in patients with alopecia areata
- Taiwanese Dermatological Association consensus on the diagnosis and management of alopecia areata